Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer
Y.-B. Shi, S.-L. Liu, X.-R. Mou, J. Liao, J.-P. Che, X.-Q. Fei, A.-R. Wang Department of Cardiothoracic Surgery, Yantai Mountain Hospital, Yantai, China
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer, by Y.-B. Shi, S.-L. Liu, X.-R. Mou, J. Liao, J.-P. Che, X.-Q. Fei, A.-R. Wang, published in Eur Rev Med Pharmacol Sci 2020; 24 (3): 1243-1249–DOI: 10.26355/eurrev_202002_20177–PMID: 32096154” has been withdrawn.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/20177
Free PDF Download![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
Y.-B. Shi, S.-L. Liu, X.-R. Mou, J. Liao, J.-P. Che, X.-Q. Fei, A.-R. Wang
Long noncoding RNA HOXA-AS2 acts as an oncogene by targeting miR-145-3p in human non-small cell lung cancer
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 17
Pages: 8629-8629
DOI: 10.26355/eurrev_202009_22775